Batten disease fundraiser tops target as family seeks safer transport for seven-year-old
A fundraising appeal for a seven-year-old girl living with Batten disease has passed its target, giving her family a clearer path to something practical and immediate: a wheelchair-accessible van. The campaign, launched for Mabel in Cleveleys, Lancashire, has now raised more than £11,000 after friends, relatives and strangers responded to the family’s plea.
For a child with a progressive neurodegenerative disorder, transport is never just transport. It becomes part of the treatment burden, the daily logistics of care and, over time, the measure of how much physical support a family can manage without outside help.
Mabel was diagnosed with Batten disease at the age of four. Her mother, Cheryl, said the illness has already left her unable to walk or talk and reliant on a wheelchair. She also struggles with eating and drinking, a reminder that the disease affects far more than movement alone. Batten disease is a rare degenerative condition of the nervous system, and in children it steadily erodes skills that were once ordinary parts of daily life.
Transport has become a clinical problem, not just a family inconvenience
The family’s need for a wheelchair-accessible van grew as lifting Mabel in and out of their car became increasingly difficult. That change may sound mechanical, but for families managing severe disability it can mark the point where each appointment becomes more physically taxing and more risky. Repeated transfers place strain on carers and can complicate regular journeys to specialist treatment.
Mabel attends regular enzyme therapy at Royal Manchester Children’s Hospital. The treatment cannot cure Batten disease, but it helps slow some of its symptoms. In progressive lysosomal storage disorders such as this, therapy is aimed at altering the pace of decline rather than reversing it. Even when a treatment does not restore lost function, it can still matter because it may preserve a narrower window of independence, comfort or stability.
The family’s fundraising page had raised £5,256 a month ago toward a £10,000 goal. It has now moved beyond £11,300. A group of Cheryl’s friends took on a 9-mile Tough Mudder assault course at Tatton Park in Cheshire to support the appeal, turning physical endurance into a practical contribution for a child whose own mobility is progressively limited by disease.
Progressive vision loss adds another layer of fear
Cheryl said the hardest part is knowing the condition will continue to worsen. One of the symptoms is eyesight degeneration and eventual blindness, and that possibility has become the family’s next fear. In Batten disease, loss of vision is not an isolated problem; it often sits within a broader neurological decline that can affect communication, walking, swallowing and daily interaction with the world.
That pattern explains why families often describe the illness in terms of successive losses. First a child may stop walking safely, then speech becomes impossible, then feeding becomes harder, and later sight begins to fade. Each stage changes not only the clinical picture but the shape of care at home. A diagnosis made in early childhood can therefore reshape family life for years, long before adulthood is ever in view.
Cheryl and her husband Chris, both 42, have spoken about the burden of transport and the increasing importance of securing equipment that matches their daughter’s needs. A wheelchair-accessible van would reduce the physical effort required for routine journeys and make travel to hospital more manageable. For families in this position, adaptive transport can determine whether specialist care remains sustainable or becomes an exhausting ordeal.
Enzyme therapy offers support, not a cure
Mabel’s treatment course reflects a larger reality of rare pediatric neurodegenerative disease: available therapies may slow symptoms without stopping the underlying disease biology. That leaves families balancing hope with practical adaptation. The hospital appointments continue. The transfers continue. The child’s needs continue to expand.
In this case, the appeal’s success does not alter the disease itself, but it does affect the setting in which care is delivered. Access to the right vehicle can ease the repeated strain of attending hospital, reduce dependence on improvised transfers and give the family a safer way to keep up with treatment. Those are not small changes when a child requires ongoing specialist follow-up.
Cheryl said the kindness shown by supporters has been humbling and overwhelming. For families facing a rare diagnosis with no cure, public support often becomes more than financial assistance; it becomes a signal that the burden of care has been seen. The money raised will now help secure the van the family says they need as Mabel’s condition progresses.
Batten disease remains an incurable illness affecting the nervous system, and Mabel’s case illustrates the cumulative demands it places on a young child and her carers. The next practical challenge is not theoretical. It is the daily reality of getting her safely to treatment, with as little physical strain as possible, while the disease continues to advance.